CIK 0001490978
- Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954284541
- Phone
- +1 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 1,499 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award Director acquired 5,997 shares (grant or award)
- 4 Grant or award See Remarks acquired 14,063 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP & CFO acquired 9,375 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President of R&D, Therapeutics sold 16,723 shares at an average $25.09 ($419,570)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP & Controller sold 666 shares at $21.11 ($14,059)
- 4 Open-market sale EVP & CFO sold 5,491 shares at $21.76 ($119,484)
- 4 Grant or award President of R&D, Therapeutics acquired 15,625 shares (grant or award)
- 4 Grant or award President & CEO acquired 37,500 shares (grant or award)
Page 3 of 17 · 326 filings